March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Cell-based Therapy In A Mouse Model Of Leber Congenital Amaurosis
Author Affiliations & Notes
  • Yi-Sheng Chang
    National Eye Institute, National Institutes of Health, Bethesda, Maryland
    Department of Ophthalmology, National Cheng Kung University, Tainan, Taiwan
  • Winnette McIntosh Ambrose
    National Eye Institute, National Institutes of Health, Bethesda, Maryland
  • Chris Lin
    National Eye Institute, National Institutes of Health, Bethesda, Maryland
  • Haohua Qian
    National Eye Institute, National Institutes of Health, Bethesda, Maryland
  • Tiansen Li
    National Eye Institute, National Institutes of Health, Bethesda, Maryland
  • Tiziana Cogliati
    National Eye Institute, National Institutes of Health, Bethesda, Maryland
  • Anand Swaroop
    National Eye Institute, National Institutes of Health, Bethesda, Maryland
  • Footnotes
    Commercial Relationships  Yi-Sheng Chang, None; Winnette McIntosh Ambrose, None; Chris Lin, None; Haohua Qian, None; Tiansen Li, None; Tiziana Cogliati, None; Anand Swaroop, None
  • Footnotes
    Support  National Health Research Insitutes, Taiwan
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 5841. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yi-Sheng Chang, Winnette McIntosh Ambrose, Chris Lin, Haohua Qian, Tiansen Li, Tiziana Cogliati, Anand Swaroop; Cell-based Therapy In A Mouse Model Of Leber Congenital Amaurosis. Invest. Ophthalmol. Vis. Sci. 2012;53(14):5841.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Mutations in CEP290 are responsible for almost 25% of Leber congenital amaurosis (LCA). We have recently described the rd16/Nrl-/- mouse model that exhibits similarity to patients with CEP290-LCA (Cideciyan et al. Hum Mol Genet. 20:1411-1423, 2011). The goal of this project is to investigate the therapeutic effect of retinal cells transplanted into the degenerating retina from this cone-only mouse model.

Methods: : Cells were dissociated from whole retina of the wild-type Nrl-GFP mice at postnatal day 3-5, and then transplanted into the cone-only degenerating retina of rd16/Nrl-/- mice at P14 by subretinal injection. Fundus photography, histology, immunohistochemistry and electroretinogram (ERG) were used for assessing the morphology and retinal function.

Results: : White dots on the retina and pseudorosettes (whorls) on the histology were characteristics of cones in rd16/Nrl-/- mice. They appeared at 2 weeks of age and reached the peak at 1 month. However, these cones underwent degeneration, as evidenced by retinal hyperpigmentation since 1.5 months of age followed by vascular attenuation. ERG recordings showed progressively decreasing responses (25% at 2 months and 15% at 3 months), compared with those at 1 month. When the transplantation was done at P14, donor rod cells (as marked by GFP expression) 2 weeks later showed morphological changes, including outer segment development (or neurite outgrowth) and integration. The donor cells survived at 2 months after transplantation. ERG recordings showed improvement of the scotopic a-wave amplitude.

Conclusions: : Retinal cell replacement may be helpful for preserving the retinal function. Meticulous procedures are mandatory for a successful transplantation. The rd16/Nrl-/- mouse retina can serve as a model for understanding the preservation of cones in foveal region of patients with CEP290 (or other) mutations and for optimizing the protocols for cell-based therapy.

Keywords: transplantation • retinal degenerations: hereditary • electroretinography: non-clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×